Targeting lncRNAs in programmed cell death as a therapeutic strategy for non-small cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Non-small cell lung cancer (NSCLC) remains a major cause of cancer mortality globally.
• Current NSCLC therapies have limitations in efficacy and side effect profiles, necessitating novel therapeutic targets.
• Long non-coding RNAs (lncRNAs) are implicated in cancer development and progression, including NSCLC.

Purpose of the Study:

• To review the role of lncRNAs in regulating programmed cell death (PCD) pathways in NSCLC.
• To summarize the therapeutic potential of targeting lncRNAs involved in PCD for NSCLC treatment.
• To provide insights into NSCLC pathogenesis and propose new therapeutic strategies.

Main Methods:

• Literature review focusing on lncRNAs and their association with various PCD mechanisms (apoptosis, pyroptosis, autophagy, ferroptosis).
• Analysis of how lncRNAs modulate these PCD pathways in the context of NSCLC progression.
• Examination of studies investigating therapeutic strategies targeting lncRNAs for NSCLC.

Main Results:

• lncRNAs are significantly correlated with multiple PCD pathways, influencing NSCLC cell death and tumor progression.
• Dysregulation of specific lncRNAs can promote or inhibit NSCLC development by affecting PCD.
• Targeting lncRNAs involved in PCD presents a promising avenue for enhancing NSCLC treatment efficacy.

Conclusions:

• lncRNAs play a critical role in governing PCD in NSCLC, impacting disease progression and therapeutic responses.
• Targeting lncRNAs within PCD pathways offers a novel and potentially effective strategy for NSCLC therapy.
• Further research into lncRNA-PCD interactions could lead to improved clinical outcomes for NSCLC patients.